Gut bugs may hold key to cancer drug side effect
NCT ID NCT07264998
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether the natural bacteria in your gut affect diarrhea caused by the breast cancer drug abemaciclib. Researchers will compare stool samples from 60 women who get diarrhea with those who don't. No new treatments are given—just observation to learn why some people have this side effect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict or prevent diarrhea in breast cancer patients taking abemaciclib, improving treatment comfort.
- What could go wrong
- This is a small observational study with no intervention, so it cannot prove cause and effect. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABEMACICLIB are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, 430079, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartwatch could spot nerve damage before it starts
- Can acupuncture soothe the mind and body in breast cancer?
- CT scans may predict breast reconstruction flap failure
- Virtual therapy may ease breast cancer treatment side effects
- A gentle jog might be the key to better sleep for breast cancer survivors
- Peer power: could community education boost cancer screening?